Books by Unknown Author
Innovation in Drug Research and Development for Prevalent Chronic Diseases
2021
Innovation in Drug Research and Development for Prevalent Chronic Diseases
2021
Public Engagement and Clinical Trials : New Models and Disruptive Technologies
2012
Public Engagement and Clinical Trials : New Models and Disruptive Technologies
2012
Public Engagement and Clinical Trials : New Models and Disruptive Technologies
2012
Facing the Reality of Drug-Resistant Tuberculosis in India
2012
Facing the Reality of Drug-Resistant Tuberculosis in India : Challenges and Potential Solutions
2012
Facing the Reality of Drug-Resistant Tuberculosis in India : Challenges and Potential Solutions
2012
Facing the Reality of Drug-Resistant Tuberculosis in India
2012
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development
2012
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development
2012
Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020
2012
Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020
2012
Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020
2012
Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020
2012
Accelerating the Development of New Drugs and Diagnostics : Maximizing the Impact of the Cures Acceleration Network
2012
Accelerating the Development of New Drugs and Diagnostics : Maximizing the Impact of the Cures Acceleration Network
2012
Building a National Framework for the Establishment of Regulatory Science for Drug Development
2011
Building a National Framework for the Establishment of Regulatory Science for Drug Development
2011
Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa
2011
Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa : Global and Local Challenges and Solutions
2011
New Profile of Drug-Resistant Tuberculosis in Russia : A Global and Local Perspective
2011
Building a National Framework for the Establishment of Regulatory Science for Drug Development
2011
Building a National Framework for the Establishment of Regulatory Science for Drug Development
2011
Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa : Global and Local Challenges and Solutions
2011
Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa : Global and Local Challenges and Solutions
2011
Advancing Regulatory Science for Medical Countermeasure Development
2011
Advancing Regulatory Science for Medical Countermeasure Development
2011
New Profile of Drug-Resistant Tuberculosis in Russia : A Global and Local Perspective
2011
New Profile of Drug-Resistant Tuberculosis in Russia : A Global and Local Perspective
2011
Public Health Emergency Medical Countermeasures Enterprise : Innovative Strategies to Enhance Products from Discovery Through Approval
2010
Public Health Emergency Medical Countermeasures Enterprise
2010
Transforming Clinical Research in the United States : Challenges and Opportunities
2010
Transforming Clinical Research in the United States : Challenges and Opportunities
2010
Accelerating the Development of Biomarkers for Drug Safety
2009
Accelerating the Development of Biomarkers for Drug Safety
2009
Accelerating the Development of Biomarkers for Drug Safety
2009
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
2009
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
2009
Addressing the Barriers to Pediatric Drug Development
2008
Emerging Safety Science
2008
Emerging Safety Science
2008
Addressing the Barriers to Pediatric Drug Development
2008
Emerging Safety Science
2008
Addressing the Barriers to Pediatric Drug Development
2008
Understanding the Benefits and Risks of Pharmaceuticals
2007
Challenges for the FDA : The Future of Drug Safety
2007
Understanding the Benefits and Risks of Pharmaceuticals
2007
Adverse Drug Event Reporting : The Roles of Consumers and Health-Care Professionals
2007
Challenges for the FDA
2007